XOOMAR

Femasys (FEMY)

Femasys on one page: short interest, daily short volume, fails to deliver, large holders, 13F holders, earnings dates and insider trades. Listed on Nasdaq.

Download CSV

164K

Short interest

settlement 2026-10-15

1.5

Days to cover

-5.8 days vs prior

24.2%

Short share of volume

2026-11-03

1,552

Fails to deliver

settlement 2026-10-09

Fri 13 Nov

Next earnings

estimated date

$134K

Insider flow, 90 days

5 buys, 0 sells

As of 2026-11-03.

Short interest

FINRA, twice a month. The newest 48 settlements in the table, 48 in the chart. JSON

As of 15 October 2026, short interest in FEMY is 164,106 shares, down 448,513 shares over the last month. Over the last 48 readings it ranged from 144,684 shares (31 January 2025) to 5,264,004 shares (31 October 2025). The latest reading sits at the bottom of that range. At the reported average volume of 108K shares a day that is 1.5 days to cover.

Embed this chart.The embed keeps its attribution line.
<iframe src="https://xoomar.com/embed/stocks/femy" width="100%" height="440" style="border:0;max-width:100%" loading="lazy" title="XOOMAR chart"></iframe>
PreviewDark previewAdd ?theme=dark to the src for a dark chart.
SettlementShares shortChangeAvg daily volumeDays to cover
2026-10-15164,106-71.6%108,2621.52
2026-09-30577,249-5.8%78,4757.36
2026-09-15612,619+3.3%72,4938.45
2026-08-31593,056+36.3%3,601,9051.00
2026-08-14434,999+64.2%274,5531.58
2026-07-31264,928+36.5%62,0714.27
2026-07-15194,148+2.1%30,7146.32
2026-06-30190,234-4.2%42,7684.45
2026-06-15198,600-94.0%78,2322.54
2026-05-293,326,404+70.1%3,901,8521.00
2026-05-151,955,435+1.2%456,3624.28
2026-04-301,932,263-0.0%360,6825.36
2026-04-151,932,424-5.0%387,6274.99
2026-03-312,033,876+2.4%791,3762.57
2026-03-131,985,844+2.3%525,2313.78
2026-02-271,940,365-6.3%357,8035.42
2026-02-132,071,093-5.3%559,7473.70
2026-01-302,187,527+13.7%1,299,8151.68
2026-01-151,923,634-1.2%931,4432.07
2025-12-311,947,788+7.7%1,741,0241.12
2025-12-151,808,062-7.6%1,308,7181.38
2025-11-281,957,230-33.2%2,318,5021.00
2025-11-142,930,593-44.3%17,124,8301.00
2025-10-315,264,004+50.8%12,841,1091.00
2025-10-153,490,431+150.5%12,572,4561.00
2025-09-301,393,466+13.6%787,9771.77
2025-09-151,226,802+33.9%3,309,8281.00
2025-08-29916,081+327.8%2,394,1051.00
2025-08-15214,151-41.0%309,3321.00
2025-07-31363,165+150.4%157,0332.31
2025-07-15145,056-31.7%157,0741.00
2025-06-30212,408+19.6%362,6921.00
2025-06-13177,664-81.2%554,0251.00
2025-05-30943,358+18.0%336,1952.81
2025-05-15799,303-15.3%192,3864.15
2025-04-30943,882+10.8%159,9315.90
2025-04-15851,560-27.8%275,3393.09
2025-03-311,179,066+2.5%380,1663.10
2025-03-141,149,935+74.5%801,8981.43
2025-02-28658,919+120.9%691,8781.00
2025-02-14298,248+106.1%408,4271.00
2025-01-31144,684-39.0%223,7821.00
2025-01-15237,305+5.1%68,6643.46
2024-12-31225,833-47.8%140,7141.60
2024-12-13432,781-25.4%182,8932.37
2024-11-29579,855+18.6%197,7342.93
2024-11-15489,114-7.1%290,4901.68
2024-10-31526,648+6.0%178,8282.94

Daily short volume

FINRA Reg SHO, the last 30 sessions. JSON

As of 3 November 2026, the short share of FEMY volume is 24.2%, down 13.9 points over the last five sessions. Over the last 30 readings it ranged from 14.8% (21 October 2026) to 70.2% (28 October 2026). The latest reading is 8.5 points below the 30-session average of 32.7%, on 98K shares reported.

DateShort volumeTotal volumeShort shareExempt
2026-11-0324K98K24.2%0
2026-11-0221K77K27.6%0
2026-10-3016K53K30.2%2,728
2026-10-2920K57K35.7%0
2026-10-2820K28K70.2%0
2026-10-2745K117K38.0%0
2026-10-2615K71K20.5%0
2026-10-2347K80K58.7%4,171
2026-10-2230K87K34.3%3,467
2026-10-212K12K14.8%0
2026-10-204K14K29.3%0
2026-10-197K34K20.1%0
2026-10-1614K33K41.4%0
2026-10-1529K82K35.5%425
2026-10-1419K109K17.2%2,162
2026-10-135K22K22.8%0
2026-10-126K29K18.8%39
2026-10-0919K56K34.5%0
2026-10-0813K26K49.0%0
2026-10-079K24K39.5%0
2026-10-062K11K19.5%0
2026-10-0549K110K44.6%0
2026-10-0228K78K35.5%0
2026-10-0111K28K37.3%0
2026-09-3014K84K17.1%2,929
2026-09-2933K189K17.5%5,135
2026-09-282K7K25.8%0
2026-09-254K14K24.9%0
2026-09-2435K61K58.4%0
2026-09-235K13K38.6%0

Fails to deliver

SEC, the last 30 settlement dates with a fail. JSON

As of 9 October 2026, the fails-to-deliver balance in FEMY is 1,552 shares, up 144 shares over the last settlement date. Over the last 30 readings it ranged from 1 share (9 September 2026) to 447,433 shares (20 August 2026). The latest reading sits at the bottom of that range.

SettlementShares failedPriceValue
2026-10-091,552$2.07$3K
2026-10-081,408$2.00$3K
2026-10-0714$2.08$29
2026-10-052,304$2.05$5K
2026-10-022,490$2.12$5K
2026-10-01619$2.16$1K
2026-09-3015,011$2.09$31K
2026-09-291,629$2.38$4K
2026-09-28240$2.48$595
2026-09-245,162$2.58$13K
2026-09-21738$2.59$2K
2026-09-182,930$2.55$7K
2026-09-1715,780$2.54$40K
2026-09-164,285$2.56$11K
2026-09-091$2.68$3
2026-09-081,910$2.98$6K
2026-09-047,523$3.06$23K
2026-09-036,928$3.10$21K
2026-09-02951$3.26$3K
2026-08-3118,713$3.20$60K
2026-08-289,087$2.79$25K
2026-08-2718,327$2.92$54K
2026-08-2631,947$2.85$91K
2026-08-2586,908$2.98$259K
2026-08-24143,031$2.96$423K
2026-08-21284,322$2.73$776K
2026-08-20447,433$2.71$1.2M
2026-08-1828,920$2.16$62K
2026-08-171,127$2.29$3K
2026-08-145,241$2.29$12K

Insider trades

SEC Form 4, newest first. JSON

Insiders at FEMY reported 5 open-market buys worth $134K in the last 90 days and no open-market sells. Latest filing: Mifek Jeffrey Gerald (Chief Clinical-Medical Affairs) on 2026-08-07.

DateInsiderTitleTypeSharesPriceValueOwned after
2026-08-07Mifek Jeffrey GeraldChief Clinical-Medical AffairsBuy3K$3.20$10K3K
2026-08-07Sipos Jeremy AlexanderChief Technology OfficerBuy3K$3.20$10K3K
2026-08-07Lee-Sepsick KathyChief Executive OfficerBuy16K$3.20$50K16K
2026-08-07Elefant DovChief Financial OfficerBuy16K$3.20$50K16K
2026-08-07Canning John CharlesChief Operating OfficerBuy4K$3.20$14K4K
2025-08-27Lee-Sepsick KathyChief Executive OfficerDiscretionary trade49Kprice not stated in the filingnot stated361K
2025-08-27Elefant DovChief Financial OfficerDiscretionary trade39Kprice not stated in the filingnot stated58K
2025-06-02Lee-Sepsick KathyChief Executive OfficerDiscretionary trade34K$1.02$35K312K
2025-06-02Elefant DovChief Financial OfficerDiscretionary trade20K$1.02$20K20K
2025-06-02Currie Daniel ScottChief Operating OfficerDiscretionary trade20K$1.02$20K86K
2025-06-02Larsen CharlesDirectorDiscretionary trade25K$1.02$25K56
2021-12-15Witte William BensonDirectorOther transaction12K$0.00$012K
2021-12-15Dyett JohnDirectorOther transaction3.2M$0.00$00
2021-12-15Dyett JohnDirectorOther transaction176K$0.00$0290K
2021-06-23Dyett JohnDirector,TenPercentOwnerBuy1K$9.95$10K115K
2021-06-22Dyett JohnDirector,TenPercentOwnerConversion64Kprice not stated in the filingnot stated114K
2021-06-22Dyett JohnDirector,TenPercentOwnerBuy40K$13.00$520K50K
2021-06-22Dyett JohnDirector,TenPercentOwnerConversion2.3Mprice not stated in the filingnot stated3.2M
2021-06-22Dyett JohnDirector,TenPercentOwnerConversion948Kprice not stated in the filingnot stated948K
2021-06-22Adams John Q JRDirectorConversion91Kprice not stated in the filingnot stated131K
2021-06-22Adams John Q JRDirectorConversion109Kprice not stated in the filingnot stated240K
2021-06-22Adams John Q JRDirectorBuy40K$13.00$520K40K
2021-06-22Larsen CharlesDirectorConversion11Kprice not stated in the filingnot stated18K
2021-06-22Larsen CharlesDirectorBuy7K$13.00$91K7K
2021-06-22Uzialko Edward RDirectorConversion1.1Mprice not stated in the filingnot stated1.2M
2021-06-22Uzialko Edward RDirectorConversion30Kprice not stated in the filingnot stated30K
2021-06-22Uzialko Edward RDirectorBuy100K$13.00$1.3M128K
2021-06-18Dyett JohnDirector,TenPercentOwnerBuy10K$12.88$129K10K
2021-06-18Dyett JohnDirector,TenPercentOwnerBuy3K$13.18$33K3K

Form 4 filings are due within two business days of the trade. Insiders sell for many reasons that say nothing about the company; open-market buys are rarer.

Large holders (13D and 13G)

One row per reporting person with its latest filing, newest first. JSON

16 holders report 5% or more of FEMY in their latest filing, 4 on Schedule 13D (active intent). The largest reported stake is Nantahala Capital Partners Limited Partnership at 10.0% of the class (803,038 shares), filed 2026-08-17 for an event on 2026-08-10.

FiledFormHolderSharesOf classEvent
2026-10-1513GRyan M. Laneparent holding company, individual469K5.6%2026-09-30
2026-10-1513GEmpery Asset Management, LPinvestment adviser, partnership469K5.6%2026-09-30
2026-08-3113GStonepine Capital Management, LLCinvestment adviser, other entity625K7.2%2026-08-10
2026-08-3113GStonepine Capital, L.P.partnership625K7.2%2026-08-10
2026-08-3113GStonepine GP, LLCother entity625K7.2%2026-08-10
2026-08-3113GJon M. Plexicoparent holding company, individual625K7.2%2026-08-10
2026-08-1713DNantahala Capital Partners Limited Partnershippartnership803K10.0%2026-08-10
2026-08-1713DNantahala Capital Management, LLCinvestment adviser, other entity803K10.0%2026-08-10
2026-08-1713DWilmot B. Harkeyindividual, parent holding company803K10.0%2026-08-10
2026-08-1713DDaniel Mackindividual, parent holding company803K10.0%2026-08-10
2026-08-1413GRosalind Advisors, Inc.corporation4.7M9.9%2026-08-10
2026-08-1413GSALAMON STEVEN A Jindividual4.7M9.9%2026-08-10
2026-08-1413GAharon Gilindividual4.7M9.9%2026-08-10
2026-08-1413GRosalind Master Fund L.P.partnership4.7M9.9%2026-08-10
2026-03-1813GPharmaCyte Biotech, Inc.corporation4.9M7.9%2026-03-17
2025-11-1413G/Ano. 1Dauntless Investment Group, LLCother entity4.4M9.9%2025-09-30

13F holders

Tracked managers holding FEMY at their latest 13F. JSON

1 of the 30 tracked managers held FEMY at their latest 13F, $71K in total at quarter-end prices. Citadel Advisors is the largest at $71K (0.0% of its portfolio) as of 2026-06-30. Over the prior quarter 1 added shares and 0 cut.

FundQuarterSharesValueOf portfolioChange in shares
Citadel Advisors2026-06-3017K$71K0.00%new

Only the 30 tracked managers on the funds hub; a 13F reports long positions in US listed stock at quarter end, 45 days late, and says nothing about shorts or positions sold since.

What this page is

Femasys in the regulatory record

Regulators publish company data in separate files that never sit next to each other: FINRA's twice-monthly short interest, its daily short sale volume, the SEC's fails-to-deliver counts, and each insider's Form 4. A company page puts those series for one ticker on one URL, with planned sales, large holders, 13F holders and financials beside them, so the short position, the daily flow, the settlement fails and what insiders are doing can be read together.

Each section has its own history table, a one-line summary of the latest figures and its own JSON and CSV links, and says when its source last updated.

This page follows Femasys (FEMY), SEC CIK 1339005, listed on Nasdaq. The cross-market tables live on the short interest and insider transactions hubs.

Source and updates

Short interest
FINRA consolidated short interestSource: FINRA.Twice a month, about eight business days after settlement. Latest 2026-10-15.JSON and CSV
Daily short volume
FINRA Reg SHO daily filesSource: FINRA.Every trading day, the morning after FINRA posts it. Latest 2026-11-03.JSON and CSV
Fails to deliver
SEC fails-to-deliver dataSource: SEC.Twice a month, a few weeks after the half month ends. Latest 2026-10-09.JSON and CSV
Large holders
SEC EDGAR Schedule 13D and 13GSource: SEC.New filings appear shortly after the SEC posts them. A 13D is due within five business days of crossing 5%; a 13G follows the passive schedule. Latest 2026-10-15.JSON and CSV
13F holders
SEC EDGAR Form 13F-HRSource: SEC.Quarterly, filed within 45 days of quarter end; 30 tracked managers. Latest 2026-06-30.JSON and CSV
Earnings dates
SEC EDGAR 8-K filings (Item 2.02)Source: SEC.Twice a day. Reported dates come from the company's 8-K filings; the next date is marked as an estimate until the 8-K arrives. Latest 2026-08-14.JSON and CSV
Insider trades
SEC EDGAR Form 4Source: SEC.New filings appear shortly after the SEC posts them; they're due two business days after the trade. Latest 2026-08-07.JSON and CSV
Company record
EDGAR filing index for CIK 1339005Ticker, name and exchange from the SEC's company list, refreshed weekly.
Rate limits
10 requests a minute without a key, 30 with a free key from a free account.

How to read it

  • Read the position against the flow: rising short interest with a high daily short share is new shorting; rising short interest with a normal short share is old shorts holding on.
  • Insider buys next to a large short position are rare and stand out; insider sells next to one are common and mean little.
  • Fails to deliver matter relative to the float, not in absolute shares; a million failed shares in a mega cap is noise.

Analysis of what the data shows, not advice. XOOMAR does not recommend buying, selling or holding anything.

Datasets

Frequently Asked Questions

How much of FEMY is sold short?
164,106 shares were held short at the 2026-10-15 settlement, 1.5 days of average volume. FINRA publishes the next count about eight business days after the 15th and the last business day of the month.
What is FEMY's daily short volume?
On 2026-11-03, 23,637 of the 97,759 FEMY shares reported to FINRA were sold short, 24.2% of the day's reported volume. Short volume is a flow for one day, not a position.
Does FEMY have fails to deliver?
The SEC's latest file shows 1,552 FEMY shares failed to deliver at settlement 2026-10-09. Fails are reported per settlement date and published twice a month with a lag.
Are FEMY insiders buying or selling?
Insiders at FEMY reported 5 open-market buys worth $134K in the last 90 days and no open-market sells. Latest filing: Mifek Jeffrey Gerald (Chief Clinical-Medical Affairs) on 2026-08-07.
Who owns 5% or more of FEMY?
16 holders report 5% or more of FEMY in their latest filing, 4 on Schedule 13D (active intent). The largest reported stake is Nantahala Capital Partners Limited Partnership at 10.0% of the class (803,038 shares), filed 2026-08-17 for an event on 2026-08-10.
Which tracked 13F managers own FEMY?
1 of the 30 tracked 13F managers held FEMY shares at their latest filing, $71K in all. The largest: Ken Griffin's Citadel Advisors (17K shares, $71K).

Data on this page is provided for informational purposes only and is not financial advice. See our editorial policy.